Akoya Biosciences Inc (AKYA)

Sector:
INFORMATION TECHNOLOGY
Industry:
ELECTRONIC EQUIPMENT
CEO:
Brian McKelligon
Employees:
100 CAMPUS DRIVE, 6TH FLOOR, MARLBOROUGH, MA 01762
855.896.8401

We are an innovative life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Our mission is to deliver a revolutionary new class of spatially derived biomarkers that empower life sciences researchers to better understand disease and clinicians to improve patient outcomes. Our principal executive offices are located at 100 Campus Drive, 6th Floor, Marlborough, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 372.879 Million Shares Outstanding37.475 Million Avg 30-day Volume 74.081 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.2
Price to Revenue7.4985 Debt to Equity0.2692 EBITDA-37.217 Million
Price to Book Value3.3934 Operating Margin-71.55890000000001 Enterprise Value331.382 Million
Current Ratio5.087 EPS Growth0.818 Quick Ratio4.426
1 Yr BETA 1.534 52-week High/Low 23.44 / 8.02 Profit Margin-78.1816
Operating Cash Flow Growth-427.0788 Altman Z-Score3.1126 Free Cash Flow to Firm -32.577 Million
Earnings Report2022-08-09

View recent insider trading info

Akoya Biosciences Inc YCharts
Yahoo! Finance finviz

Funds Holding AKYA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AKYA BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

75.1 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

RAMACHANDRAN NIRO PH.D CHIEF BUSINESS OFFICER

  • Officer
 219,246 2022-04-13 3

EL-GABRY EHAB CHIEF MEDICAL OFFICER

  • Officer
 0 2022-04-11 1

DRISCOLL JOSEPH CHIEF FINANCIAL OFFICER

  • Officer
 37,500 2022-03-23 1

PLA FREDERIC CHIEF OPERATING OFFICER

  • Officer
 67,500 2022-03-23 1

MCKELLIGON BRIAN PRESIDENT/CEO

  • Officer
 240,000 2022-03-23 1

MOY MARILEE CHIEF PEOPLE OFFICER

  • Officer
 120,000 2022-02-24 2

NOLAN GARRY PH.D.

  • Director
 655,084 2021-12-09 1

MENDEL SCOTT

  • Director
 8,500 2021-11-19 3

SHEPLER ROBERT G

  • Director
 249,592 2021-11-18 1

LAI GOLDMAN MYLA

  • Director
 0 2021-09-16 2

SCHNETTLER THOMAS P

  • Director
 2,830,631 2021-05-21 0

RAFFIN THOMAS A.

  • Director
  • 10% Owner
 16,110,291 2021-05-21 0

WINKLER MATTHEW

  • Director
 797,985 2021-05-21 0

RAFFIN THOMAS A.

MACKOWSKI J MATTHEW

LASHKARI DEVAL

TELEGRAPH HILL PARTNERS III, L.P.

THP III AFFILIATES FUND, LLC

TELEGRAPH HILL PARTNERS III INVESTMENT MANAGEMENT, LLC

TELEGRAPH HILL PARTNERS MANAGEMENT COMPANY, LLC

  • Director
  • 10% Owner
 16,104,431 2021-04-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

RAMACHANDRAN NIRO PH.D - Officer CHIEF BUSINESS OFFICER

2022-04-14 15:23:26 -0400 2022-04-13 M 75,107 d 96,566 direct

RAMACHANDRAN NIRO PH.D - Officer CHIEF BUSINESS OFFICER

2022-04-14 15:23:26 -0400 2022-04-13 M 75,107 $0.91 a 122,680 direct 0.0 -9.2527 0.0 1 -9.2527 6

DRISCOLL JOSEPH - Officer CHIEF FINANCIAL OFFICER

2022-03-25 19:23:24 -0400 2022-03-23 A 12,500 a 12,500 direct 3.5584 -1.7336 -11.5876 3.5584 2 -23.5401 30

PLA FREDERIC - Officer CHIEF OPERATING OFFICER

2022-03-25 19:22:14 -0400 2022-03-23 A 45,000 a 45,000 direct

MCKELLIGON BRIAN - Officer PRESIDENT/CEO

2022-03-25 19:25:48 -0400 2022-03-23 A 80,000 a 80,000 direct 3.5584 -1.7336 -11.5876 3.5584 2 -23.5401 30

PLA FREDERIC - Officer CHIEF OPERATING OFFICER

2022-03-25 19:22:14 -0400 2022-03-23 A 22,500 a 22,500 direct 3.5584 -1.7336 -11.5876 3.5584 2 -23.5401 30

RAMACHANDRAN NIRO PH.D - Officer CHIEF BUSINESS OFFICER

2022-03-25 19:24:37 -0400 2022-03-23 A 45,000 a 45,000 direct

DRISCOLL JOSEPH - Officer CHIEF FINANCIAL OFFICER

2022-03-25 19:23:24 -0400 2022-03-23 A 25,000 a 25,000 direct

RAMACHANDRAN NIRO PH.D - Officer CHIEF BUSINESS OFFICER

2022-03-25 19:24:37 -0400 2022-03-23 A 22,500 a 47,573 direct 3.5584 -1.7336 -11.5876 3.5584 2 -23.5401 30

MCKELLIGON BRIAN - Officer PRESIDENT/CEO

2022-03-25 19:25:48 -0400 2022-03-23 A 160,000 a 160,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AKOYA BIOSCIENCES INC AKYA 2022-05-20 22:15:03 UTC -0.8209 1.6409 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 21:45:03 UTC -0.8209 1.6409 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 21:15:03 UTC -0.8209 1.6409 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 20:45:03 UTC -0.7755 1.5955 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 20:15:05 UTC -0.7755 1.5955 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 19:45:03 UTC -0.7755 1.5955 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 19:15:04 UTC -0.7755 1.5955 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 18:45:03 UTC -0.7691 1.5891 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 18:15:03 UTC -0.7691 1.5891 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 17:45:03 UTC -0.7691 1.5891 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 17:15:03 UTC -0.7691 1.5891 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 16:45:04 UTC -0.7439 1.5639 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 16:15:03 UTC -0.7439 1.5639 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 15:45:03 UTC -0.7439 1.5639 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 15:15:03 UTC -0.7439 1.5639 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 14:45:03 UTC -0.5251 1.3451 15000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 14:15:04 UTC -0.5251 1.3451 10000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 13:45:03 UTC -0.5251 1.3451 10000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 13:15:03 UTC -0.5251 1.3451 10000
AKOYA BIOSCIENCES INC AKYA 2022-05-20 12:45:03 UTC -0.5251 1.3451 10000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments